Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Lilly's Pivotal Phase 3 Atopic Dermatitis Studies
Posted:
Millions of people with atopic dermatitis cope with both seen and unseen burdens of the disease. Discover more about important new clinical trial results and how Lilly is helping to improve care and understanding of this disease here.
What you need to do to place a medical device on the Great Britain, Northern Ireland and European Union (EU) markets.
This guidance is divided into sections on the different rules that apply in Great Britain, Northern Ireland and the…
Calling innovators in these spaces:
Advanced Manufacturing
Clean Energy Industries
Creative Industries
Defence
Digital and Technologies
Life Sciences
Medical Technologies Innovation Facility (MTIF) is looking for collaborators for the UKRI Innovate UK Advanced manufacturing supply chain innovation challenge.
Read more…
Attendees
Sponsors and Exhibitors
Contact us